Omics-based molecular target and biomarker identification
- PMID: 21370102
- PMCID: PMC3742302
- DOI: 10.1007/978-1-61779-027-0_26
Omics-based molecular target and biomarker identification
Abstract
Genomic, proteomic, and other omic-based approaches are now broadly used in biomedical research to facilitate the understanding of disease mechanisms and identification of molecular targets and biomarkers for therapeutic and diagnostic development. While the Omics technologies and bioinformatics tools for analyzing Omics data are rapidly advancing, the functional analysis and interpretation of the data remain challenging due to the inherent nature of the generally long workflows of Omics experiments. We adopt a strategy that emphasizes the use of curated knowledge resources coupled with expert-guided examination and interpretation of Omics data for the selection of potential molecular targets. We describe a downstream workflow and procedures for functional analysis that focus on biological pathways, from which molecular targets can be derived and proposed for experimental validation.
Figures







Similar articles
-
Computational analysis workflows for Omics data interpretation.Methods Mol Biol. 2011;719:379-97. doi: 10.1007/978-1-61779-027-0_17. Methods Mol Biol. 2011. PMID: 21370093
-
Confero: an integrated contrast data and gene set platform for computational analysis and biological interpretation of omics data.BMC Genomics. 2013 Jul 29;14:514. doi: 10.1186/1471-2164-14-514. BMC Genomics. 2013. PMID: 23895370 Free PMC article.
-
Omics-bioinformatics in the context of clinical data.Methods Mol Biol. 2011;719:479-97. doi: 10.1007/978-1-61779-027-0_22. Methods Mol Biol. 2011. PMID: 21370098
-
Computational Methods and Software Tools for Functional Analysis of miRNA Data.Biomolecules. 2020 Aug 28;10(9):1252. doi: 10.3390/biom10091252. Biomolecules. 2020. PMID: 32872205 Free PMC article. Review.
-
Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.Prog Brain Res. 2006;158:83-108. doi: 10.1016/S0079-6123(06)58004-5. Prog Brain Res. 2006. PMID: 17027692 Review.
Cited by
-
The search for drug-targetable diagnostic, prognostic and predictive biomarkers in chronic graft-versus-host disease.Expert Rev Clin Immunol. 2018 May;14(5):389-404. doi: 10.1080/1744666X.2018.1463159. Epub 2018 Apr 19. Expert Rev Clin Immunol. 2018. PMID: 29629613 Free PMC article. Review.
-
Blood-Based Biomarkers for Managing Workload in Athletes: Perspectives for Research on Emerging Biomarkers.Sports Med. 2023 Nov;53(11):2039-2053. doi: 10.1007/s40279-023-01866-5. Epub 2023 Jun 21. Sports Med. 2023. PMID: 37341908 Free PMC article.
-
Automated biomarker candidate discovery in imaging mass spectrometry data through spatially localized Shapley additive explanations.Anal Chim Acta. 2021 Sep 8;1177:338522. doi: 10.1016/j.aca.2021.338522. Epub 2021 Apr 26. Anal Chim Acta. 2021. PMID: 34482894 Free PMC article.
-
Genome-wide epigenomic profiling for biomarker discovery.Clin Epigenetics. 2016 Nov 21;8:122. doi: 10.1186/s13148-016-0284-4. eCollection 2016. Clin Epigenetics. 2016. PMID: 27895806 Free PMC article. Review.
-
Biomarker selection and classification of "-omics" data using a two-step bayes classification framework.Biomed Res Int. 2013;2013:148014. doi: 10.1155/2013/148014. Epub 2013 Sep 11. Biomed Res Int. 2013. PMID: 24106694 Free PMC article.
References
-
- Ransohoff DF. Cancer. Developing molecular biomarkers for cancer. Science. 2003;299:1679–80. - PubMed
-
- Riesterer O, Milas L, Ang KK. Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy. J Clin Oncol. 2007;25:4075–83. - PubMed
-
- Kim YS, Maruvada P, Milner JA. Metabolomics in biomarker discovery: future uses for cancer prevention. Future Oncol. 2008;4:93–102. - PubMed
-
- Hanash S. Integrated global profiling of cancer. Nat Rev Cancer. 2004;4:638–44. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources